Iovance Biotherapeutics : Results of Operations and Financial Condition
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to...
Source: marketscreener.com
Stay updated with breaking news from Interactive Date File. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to...
Item 1.01. Entry Into a Material Definitive Agreement. On June 16, 2023, Iovance Biotherapeutics, Inc. entered into a new Open Market Sale Agreement with Jefferies LLC with respect to an at the... | June 16, 2023